Shares of Asante Solutions Inc (NASDAQ:PUMP) have received an average rating of “Buy” from the nineteen research firms that are covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, four have given a hold recommendation, thirteen have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month target price among analysts that have issued a report on the stock in the last year is $21.17.
PUMP has been the topic of several recent analyst reports. Royal Bank of Canada set a $24.00 target price on Asante Solutions and gave the stock a “buy” rating in a report on Thursday, December 21st. SunTrust Banks started coverage on Asante Solutions in a report on Wednesday, December 20th. They issued a “buy” rating and a $27.00 price target on the stock. Zacks Investment Research lowered Asante Solutions from a “strong-buy” rating to a “hold” rating in a report on Thursday, January 4th. Piper Jaffray set a $19.00 price target on Asante Solutions and gave the company a “buy” rating in a report on Wednesday, March 28th. Finally, Jefferies Group set a $21.00 price target on Asante Solutions and gave the company a “buy” rating in a report on Tuesday, March 27th.
PUMP stock traded down $0.38 during midday trading on Friday, hitting $16.32. 920,716 shares of the company’s stock were exchanged, compared to its average volume of 1,546,832. Asante Solutions has a one year low of $10.84 and a one year high of $22.88.
Asante Solutions (NASDAQ:PUMP) last posted its earnings results on Monday, March 26th. The company reported $0.12 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.37 by ($0.25). The business had revenue of $313.70 million during the quarter, compared to analysts’ expectations of $313.34 million. The business’s revenue for the quarter was up 11.0% compared to the same quarter last year.
Large investors have recently added to or reduced their stakes in the stock. Exane Derivatives acquired a new stake in shares of Asante Solutions in the fourth quarter valued at about $108,000. Quantitative Systematic Strategies LLC acquired a new stake in shares of Asante Solutions in the fourth quarter valued at about $329,000. Metropolitan Life Insurance Co. NY acquired a new stake in shares of Asante Solutions in the fourth quarter valued at about $378,000. MetLife Investment Advisors LLC acquired a new stake in shares of Asante Solutions in the fourth quarter valued at about $551,000. Finally, ETRADE Capital Management LLC acquired a new stake in shares of Asante Solutions in the fourth quarter valued at about $738,000.
TRADEMARK VIOLATION NOTICE: “Asante Solutions Inc (PUMP) Given Consensus Rating of “Buy” by Brokerages” was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this news story on another site, it was copied illegally and reposted in violation of US & international copyright law. The original version of this news story can be accessed at https://www.dispatchtribunal.com/2018/04/07/asante-solutions-inc-pump-given-consensus-rating-of-buy-by-brokerages.html.
About Asante Solutions
Asante Solutions, Inc is a medical device company. The Company is a manufacturer of Asante Snap Insulin Pump System (Snap system), which is a pump featuring a modular design with pre-filled insulin cartridges and disposable pump bodies, utilized in combination with a controller. The Snap system comprises four components: the Snap system controller, a disposable pump body, disposable pre-filled insulin cartridges and disposable infusion sets.
Receive News & Ratings for Asante Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Asante Solutions and related companies with MarketBeat.com's FREE daily email newsletter.